Related Experiment Video
Updated: Sep 5, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Nuclear Receptor RORα/γ: Exciting Modulators in Metabolic Syndrome and Related Disorders
Haotian Gu1, Ping Hu1, Yahui Zhao1
1College of Animal Science and Technology, Yangzhou University, Yangzhou, China.
Abstract:
Under the influences of modern lifestyle, metabolic syndromes (MetS), including insulin resistance, obesity, and fatty liver, featuring a worldwide chronic disease, greatly raise the risk of type 2 diabetes, heart disease, and stroke. However, its pathogenesis is still unclear, and there are limited drugs with strong clinical efficacy and specificity. Given the close connection between impaired lipid metabolism and MetS onset, modulating the lipid metabolic genes may provide potential prospects in the development of MetS therapeutics. Nuclear receptors are such druggable transcription factors that translate physiological signals into gene regulation via DNA binding upon ligand activation. Recent studies reveal vital functions of the NRs retinoic acid's receptor-related orphan receptors (RORs), including RORα and RORγ, in the gene regulation in lipid metabolism and MetS. This review focuses on the latest developments in their actions on MetS and related metabolic disorders, which would benefit future clinically therapeutic applications.
Insights
Metabolic syndromes (MetS) are linked to impaired lipid metabolism. Nuclear receptors RORα and RORγ show potential for developing new MetS therapeutics by regulating lipid metabolism genes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Molecular Biology
Background:
- Metabolic syndromes (MetS) are prevalent chronic diseases increasing risks for type 2 diabetes, heart disease, and stroke.
- The exact pathogenesis of MetS remains unclear, with limited effective and specific therapeutic drugs available.
- Impaired lipid metabolism is closely associated with MetS development, suggesting gene modulation as a therapeutic strategy.
Purpose of the Study:
- To review the latest research on the roles of retinoic acid's receptor-related orphan receptors (RORs), specifically RORα and RORγ, in lipid metabolism.
- To explore the involvement of RORα and RORγ in the pathogenesis of MetS and related metabolic disorders.
- To highlight the potential of targeting RORs for future therapeutic applications in managing MetS.
Main Methods:
- Literature review of recent studies on nuclear receptors (NRs) and their function in lipid metabolism.
- Analysis of research focusing on RORα and RORγ gene regulation in the context of metabolic disorders.
- Synthesis of findings related to the therapeutic potential of modulating RORs for MetS.
Main Results:
- Nuclear receptors, including RORα and RORγ, play crucial roles in regulating genes involved in lipid metabolism.
- These receptors are implicated in the development and progression of MetS and associated conditions.
- Evidence suggests that modulating ROR activity can impact lipid metabolism pathways relevant to MetS.
Conclusions:
- RORα and RORγ are key regulators of lipid metabolism and are involved in MetS pathogenesis.
- Targeting these nuclear receptors presents a promising avenue for developing novel therapeutics for metabolic syndromes.
- Further research into RORs could lead to clinically effective treatments for insulin resistance, obesity, and fatty liver disease.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Metabolism
Regulation of Nuclear Protein Sorting
Co-activators and Co-repressors
Signal Transduction: Overview
Typically, signal transduction involves three...
Global Regulatory Systems

